Litcius/Paper detail

ERBB2-Low Breast Cancer—Is It a Fact or Fiction, and Do We Have the Right Assay?

Kimberly H. Allison, Antonio C. Wolff

2022JAMA Oncology27 citationsDOI

Abstract

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue

Topics & Concepts

MedicineBreast cancerOncologyCancerMEDLINEGynecologyInternal medicineLawPolitical scienceUbiquitin and proteasome pathwaysCancer-related Molecular PathwaysGlycosylation and Glycoproteins Research
ERBB2-Low Breast Cancer—Is It a Fact or Fiction, and Do We Have the Right Assay? | Litcius